SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael M. Cubrilo who wrote (437)4/22/1998 2:26:00 PM
From: Paul S.  Read Replies (2) of 1185
 
I think Soros is speculating that possibly NRT is in negotiations with Bristol Meyers.

I too think that NRT has had an incredible run, but I do not see any signs of this slowing down. If you look at a chart, it has been a slow steady climb on good volume, not a dramatic increase like we so often see on the VSE. This does not justify cold feet, although removing your initial investment is always wise, I would remain a shareholder for the long term. On this thread there have been numerous discussions of NRT's future valuations, I think that the Co could easily meet these targets in the coming months. Remember NRT has just recently put the last piece of the puzzle together in order for it to go to the next level (CEO).

Also most junior biotechs do not report earnings but trade on the value of future earnings. If you have any doubt as to the possible short term growth of NRT, look at FMI (Forbes Meditech)and their recent share price increase. I believe that NRT has as good a shot or better to succeed like FMI.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News